000 01451 a2200397 4500
005 20250511203442.0
264 0 _c19920210
008 199202s 0 0 eng d
022 _a0002-9637
024 7 _a10.4269/ajtmh.1991.45.695
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHerrington, D A
245 0 0 _aSafety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax.
_h[electronic resource]
260 _bThe American journal of tropical medicine and hygiene
_cDec 1991
300 _a695-701 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aAntibody Formation
650 0 4 _aHumans
650 0 4 _aImmunity, Cellular
650 0 4 _aImmunologic Tests
650 0 4 _aMalaria, Vivax
_xprevention & control
650 0 4 _aPlasmodium vivax
_ximmunology
650 0 4 _aProtozoan Vaccines
_xadverse effects
650 0 4 _aVaccines, Synthetic
_xadverse effects
700 1 _aNardin, E H
700 1 _aLosonsky, G
700 1 _aBathurst, I C
700 1 _aBarr, P J
700 1 _aHollingdale, M R
700 1 _aEdelman, R
700 1 _aLevine, M M
773 0 _tThe American journal of tropical medicine and hygiene
_gvol. 45
_gno. 6
_gp. 695-701
856 4 0 _uhttps://doi.org/10.4269/ajtmh.1991.45.695
_zAvailable from publisher's website
999 _c1770192
_d1770192